Skip to main content
OpenTrials

Clinical trial condition

Inflammatory Breast Neoplasms

Explore clinical trials studying Inflammatory Breast Neoplasms. Study availability and eligibility vary by location and protocol.

74 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Inflammatory Breast Neoplasms trial results

Completed

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

NCT02876302

Conditions
Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer (IBC), +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

NCT01730833

Conditions
Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope- South Pasadena Cancer Center South Pasadena, California, United States
View Trial Details
Completed

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

NCT00066443

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada
  • Odette Cancer Centre Toronto, Ontario, Canada
  • Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

NCT05415215

Conditions
Behavior, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Centro de Investigaciones Médicas y Desarrollo LC S.R.L Buenos Aires, Ciudad Autónoma de BuenosAires, Argentina
  • Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
  • University Clinical Center of the Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • Cantonal Hospital Zenica Zenica, Bosnia and Herzegovina
View all 45 locations
View Trial Details
Completed

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

NCT00193206

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Integrated Community Oncology Network Jacksonville, Florida, United States
  • Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

NCT00464646

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Clearview Cancer Institute- Huntsville Huntsville, Alabama, United States
  • Kaiser Permanente-San Diego San Diego, California, United States
  • Kaiser Permanente-Vallejo Vallejo, California, United States
  • CCOP, Colorado Cancer Research Program, Inc. Denver, Colorado, United States
View all 36 locations
View Trial Details

Related conditions